Correlation Between Evogene and Clal Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Evogene and Clal Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evogene and Clal Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evogene and Clal Biotechnology Industries, you can compare the effects of market volatilities on Evogene and Clal Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evogene with a short position of Clal Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evogene and Clal Biotechnology.

Diversification Opportunities for Evogene and Clal Biotechnology

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Evogene and Clal is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Evogene and Clal Biotechnology Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Biotechnology and Evogene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evogene are associated (or correlated) with Clal Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Biotechnology has no effect on the direction of Evogene i.e., Evogene and Clal Biotechnology go up and down completely randomly.

Pair Corralation between Evogene and Clal Biotechnology

Assuming the 90 days trading horizon Evogene is expected to under-perform the Clal Biotechnology. In addition to that, Evogene is 1.72 times more volatile than Clal Biotechnology Industries. It trades about -0.34 of its total potential returns per unit of risk. Clal Biotechnology Industries is currently generating about -0.09 per unit of volatility. If you would invest  4,120  in Clal Biotechnology Industries on August 25, 2024 and sell it today you would lose (530.00) from holding Clal Biotechnology Industries or give up 12.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Evogene  vs.  Clal Biotechnology Industries

 Performance 
       Timeline  
Evogene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evogene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Clal Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Evogene and Clal Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Evogene and Clal Biotechnology

The main advantage of trading using opposite Evogene and Clal Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evogene position performs unexpectedly, Clal Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will offset losses from the drop in Clal Biotechnology's long position.
The idea behind Evogene and Clal Biotechnology Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements